As shown in Figure 7C–E, this treatment significantly reduced the tumor burden, as indicated by bioluminescent imaging (BLI), and markedly prolonged the overall survival of animals bearing NHA/HRasV12/TRIM24 brain tumor xenografts (P < 0.01). This evidence concerns the gene TRIM24 and neoplasm.